Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities

March 26, 2021 Auto Bot Acquire, Discovery, Expand, M&A, MedTech 0

Shots:

  • Immunai acquires the Dropprint Genomics and also expand its team with the hiring of new experts in immunology, single-cell technologies and machine learning
  • The acquisition and the new hiring will advance the Immunai’s work in single cell functional genomics to support discovery, prioritization, and development of new therapies and drug combinations
  • The acquisition happened a month after Immunai raised $60M in a Series A financing round and has raised $80M in funding to date

Click here ­to­ read full press release/ article | Ref: Web Wire | Image: 10x Genomics

The post Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities first appeared on PharmaShots.